Supreme Court preserves mail-order access to abortion pill mifepristone

The Supreme Court on Thursday kept in place, for now, broad access to the abortion pill mifepristone by mail, blocking a lower-court order that would have forced patients to get the drug in person while a legal challenge continues. The unsigned emergency order means abortion providers can keep prescribing mifepristone through telehealth and pharmacies can continue shipping it to patients, at least for the moment.

The decision is a significant temporary win for abortion providers and the drug’s manufacturers, Danco Laboratories and GenBioPro, who told the court that the appeals court ruling created confusion and could abruptly disrupt access nationwide. It also preserves the status quo for patients in states where abortion remains legal and where telehealth has become a major route to medication abortion.

The case stems from a challenge brought by Louisiana to the Food and Drug Administration’s rules on mifepristone, a drug approved by the FDA in 2000 and used with a second medicine, misoprostol, to end early pregnancies. In recent years, the FDA loosened some access requirements, including allowing the drug to be prescribed remotely and sent by mail. A federal appeals court in New Orleans later moved to reinstate in-person dispensing, saying the mail-order policy conflicted with state law.

The Supreme Court’s order does not decide the underlying legal dispute. Instead, it pauses the lower court’s restrictions while the 5th U.S. Circuit Court of Appeals considers the merits of Louisiana’s challenge. That means the long-running fight over how mifepristone can be prescribed and distributed remains alive, and the issue could return to the Supreme Court later.

The temporary reprieve comes as mifepristone has become central to abortion care in the United States. According to the Guttmacher Institute, medication abortion accounts for a large share of abortions nationwide, and the ability to receive the pills by mail has expanded access for patients who live far from clinics or face travel barriers. The debate over the drug has also become a focal point in the broader political and legal battle over abortion rights since the Supreme Court ended federal abortion protections in 2022.

The justices were divided on the emergency order, with conservative Justices Samuel Alito and Clarence Thomas dissenting, according to reporting on the case. For now, though, the practical result is that access to mifepristone by mail will continue while the courts continue to weigh one of the most closely watched abortion cases in the country.